Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: A propensity matched study: Clinical evidence of late catch-up?

International Journal of Cardiology

Volumn 152, Issue 3, 2011, Pages 302-306

  Ko, Young Guk ^a   Kim, Jung Sun ^a   Choi, Donghoon ^a   Hong, Myeong Ki ^a   Min, Pil Ki ^b   Yoon, Young Won ^b   Hong, Bum Kee ^b   Lee, Byoung Kwon ^b   Kwon, Hyuck Moon ^b   Kim, Byeong Keuk ^c   Oh, Sung Jin ^c   Jeon, Dong Wun ^c   Yang, Joo Young ^c   Jang, Yangsoo ^a  

^a Yonsei University Health System   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

Coronary artery disease; Drug eluting stent; Neointima; Restenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; REVASCULARIZATION; RISK ASSESSMENT; STENT THROMBOSIS; SURVIVAL;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROPENSITY SCORE; REGISTRIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80055048980     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.07.023     Document Type: Article

References (31)

1. M.N. Babapulle, L. Joseph, P. Bélisle, J.M. Brophy, and M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
2. M.J. Eisenberg, and K.J. Konnyu Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis Am J Cardiol 98 2006 375 382
3. S. Silber Cypher versus Taxus: are there differences? J Interv Cardiol 18 2005 441 446
4. J.J. Goy, J.C. Stauffer, M. Siegenthaler, A. Benoît, and C. Seydoux A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial J Am Coll Cardiol 45 2005 308 311
5. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
6. A.M. Galløe, L. Thuesen, and H. Kelbaek Randomized trial in everyday clinical practice: the SORT OUT II comparison of paclitaxel- and sirolimus-eluting stents JAMA 299 2008 409 416
7. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670
8. J. Mehilli, A. Dibra, and A. Kastrati Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels Eur Heart J 27 2006 260 266
9. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
10. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662
11. Y.H. Kim, S.W. Park, and S.W. Lee Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease Circulation 114 2006 2148 2153
12. C. Kaiser, H.P. Brunner-La Rocca, and P.T. Buser Incremental cost-effectiveness of drug-eluting stents compared with a third generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET) Lancet 366 2005 921 929
13. J. de Lezo, A. Medina, and M. Pan Randomized rapamycin versus paclitaxel CORPAL study (abstr) J Am Coll Cardiol 45 suppl 2005 75A
14. P. Cervinka, M.A. Costa, and D.J. Angiolillo Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study Catheter Cardiovasc Interv 67 2006 846 851
15. C.A. Simonton, B. Brodie, and B. Cheek Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry-STENT Group J Am Coll Cardiol 50 2007 1214 1222
16. S. Sidhu, N. Shafiq, S. Malhotra, P. Pandhi, and A. Grover A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease Br J Clin Pharmacol 61 2006 720 726
17. A. Kastrati, A. Dibra, and S. Eberle Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials JAMA 294 2005 819 825
18. A. Schömig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
19. H.S. Gurm, T. Boyden, and K.B. Welch Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis Am Heart J 155 2008 630 639
20. C. Stettler, S. Wandel, and S. Allemann Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
21. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
22. P.S. Teirstein, V. Massullo, and S. Jani Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial Circulation 101 2000 360 365
23. R. Waksman, A.E. Ajani, and R.L. White Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation 109 2004 340 344
24. M.A. Costa, M. Sabaté, and W.J. van der Giessen Late coronary occlusion after intracoronary brachytherapy Circulation 100 1999 789 792
25. A.J. Carter, M. Aggarwal, and G.A. Kopia Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovasc Res 63 2004 617 624
26. A. Farb, P.F. Heller, and S. Shroff Pathological analysis of local delivery of paclitaxel via a polymer-coated stent Circulation 104 2001 473 479
27. D.W. Park, M.K. Hong, and G.S. Mintz Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study J Am Coll Cardiol 48 2006 2432 2439
28. K. Tsuchida, P.W. Serruys, and N. Bruining Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial Am J Cardiol 99 2007 607 615
29. J.E. Sousa, M.A. Costa, and A. Abizaid Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents Circulation 111 2005 2326 2329
30. G.J. Wilson, G. Nakazawa, and R.S. Schwartz Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 2009 141 149
31. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150